Tamil Nadu: Cabinet approves land allocation for vaccine plant

Published On 2019-02-16 03:45 GMT   |   Update On 2019-02-16 03:45 GMT

The project entails production of viral vaccines such as TCA anti-measles vaccine, Japanese encephalitis and anti-sera at the PII, Coonoor. Land for the project will be transferred free of cost, an official statement said.


Tamil Nadu: The Union Cabinet on Wednesday approved the allotment of land to Pasteur Institute of India(PII) for setting up of new viral vaccine manufacturing unit at Coonoor in Tamil Nadu.


Also Read: GSK Pharma to invest Rs 1000 crore in Karnataka plant


The project entails production of viral vaccines such as TCA anti-measles vaccine, Japanese encephalitis and anti-sera at the PII, Coonoor. Land for the project will be transferred free of cost, an official statement said.


The allotment of land will encourage the production of life-saving vaccines for children and strengthen the vaccine security of the country. Most of these vaccines are at present imported.

The Pasteur Institute of India produces DPT vaccine and rabies vaccine for the Expanded Program on Immunization in India.


The institute was initially called the Pasteur Institute of Southern India. In 1907 it changed its name to the Pasteur Institute of India. In 1977 it became an autonomous body under the Ministry of Health and Family Welfare. The institute is named after the French scientist, Louis Pasteur.


Also Read: USFDA completes inspection at Caplin Point Lab’s sterile injectable facility in Tamil Nadu

Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News